Cargando…

A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()

The worldwide COVID-19 pandemic sparked such a wave of concern that made access to vaccines more necessary than before. As the vaccine inaccessibility in developing countries has made pandemic eradication more difficult, this study has presented a mathematical model of a sustainable SC for the COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilani, Hani, Sahebi, Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913040/
https://www.ncbi.nlm.nih.gov/pubmed/35291647
http://dx.doi.org/10.1016/j.omega.2022.102637
_version_ 1784667322465648640
author Gilani, Hani
Sahebi, Hadi
author_facet Gilani, Hani
Sahebi, Hadi
author_sort Gilani, Hani
collection PubMed
description The worldwide COVID-19 pandemic sparked such a wave of concern that made access to vaccines more necessary than before. As the vaccine inaccessibility in developing countries has made pandemic eradication more difficult, this study has presented a mathematical model of a sustainable SC for the COVID-19 vaccine that covers the economic, environmental and social aspects and provides vaccine both domestically and internationally. It has also proposed a robust data-driven model based on a polyhedral uncertainty set to address the unjust worldwide vaccine distribution as an uncertain parameter. It is acceptably robust and is also less conservative than its classical counterparts. For validation, the model has been implemented in a real case in Iran, and the results have shown that it is 21% less conservative than its classical rivals (Box and Polyhedral convex uncertainty sets) in facing the uncertain parameter. As a result, the model proposes the construction of two domestic vaccine production centers, including Pasteur Institute and Razi Institute, and five foreign distributors in Tehran, Isfahan, Ahvaz, Kermanshah, and Bandar Abbas strategically.
format Online
Article
Text
id pubmed-8913040
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89130402022-03-11 A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain() Gilani, Hani Sahebi, Hadi Omega Article The worldwide COVID-19 pandemic sparked such a wave of concern that made access to vaccines more necessary than before. As the vaccine inaccessibility in developing countries has made pandemic eradication more difficult, this study has presented a mathematical model of a sustainable SC for the COVID-19 vaccine that covers the economic, environmental and social aspects and provides vaccine both domestically and internationally. It has also proposed a robust data-driven model based on a polyhedral uncertainty set to address the unjust worldwide vaccine distribution as an uncertain parameter. It is acceptably robust and is also less conservative than its classical counterparts. For validation, the model has been implemented in a real case in Iran, and the results have shown that it is 21% less conservative than its classical rivals (Box and Polyhedral convex uncertainty sets) in facing the uncertain parameter. As a result, the model proposes the construction of two domestic vaccine production centers, including Pasteur Institute and Razi Institute, and five foreign distributors in Tehran, Isfahan, Ahvaz, Kermanshah, and Bandar Abbas strategically. Elsevier Ltd. 2022-07 2022-03-11 /pmc/articles/PMC8913040/ /pubmed/35291647 http://dx.doi.org/10.1016/j.omega.2022.102637 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gilani, Hani
Sahebi, Hadi
A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
title A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
title_full A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
title_fullStr A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
title_full_unstemmed A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
title_short A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
title_sort data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in covid-19 vaccine supply chain()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913040/
https://www.ncbi.nlm.nih.gov/pubmed/35291647
http://dx.doi.org/10.1016/j.omega.2022.102637
work_keys_str_mv AT gilanihani adatadrivenrobustoptimizationmodelbycuttinghyperplanesonvaccineaccessuncertaintyincovid19vaccinesupplychain
AT sahebihadi adatadrivenrobustoptimizationmodelbycuttinghyperplanesonvaccineaccessuncertaintyincovid19vaccinesupplychain
AT gilanihani datadrivenrobustoptimizationmodelbycuttinghyperplanesonvaccineaccessuncertaintyincovid19vaccinesupplychain
AT sahebihadi datadrivenrobustoptimizationmodelbycuttinghyperplanesonvaccineaccessuncertaintyincovid19vaccinesupplychain